Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer.
Thomas JS, Hanby AM, Russell N, van Tienhoven G, Riddle K, Anderson N, Cameron DA, Bartlett JM, Piper T, Cunningham C, Canney P, Kunkler IH; SUPREMO Trial Management Group. Thomas JS, et al. Breast Cancer Res Treat. 2017 May;163(1):63-69. doi: 10.1007/s10549-017-4145-4. Epub 2017 Feb 11. Breast Cancer Res Treat. 2017. PMID: 28190252 Free PMC article. Clinical Trial.
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others.
Bartlett JM, Bayani J, Marshall A, Dunn JA, Campbell A, Cunningham C, Sobol MS, Hall PS, Poole CJ, Cameron DA, Earl HM, Rea DW, Macpherson IR, Canney P, Francis A, McCabe C, Pinder SE, Hughes-Davies L, Makris A, Stein RC; OPTIMA TMG. Bartlett JM, et al. J Natl Cancer Inst. 2016 Apr 29;108(9):djw050. doi: 10.1093/jnci/djw050. Print 2016 Sep. J Natl Cancer Inst. 2016. PMID: 27130929 Free PMC article. Clinical Trial.
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer.
Bayani J, Poncet C, Crozier C, Neven A, Piper T, Cunningham C, Sobol M, Aebi S, Benstead K, Bogler O, Dal Lago L, Fraser J, Hilbers F, Hedenfalk I, Korde L, Linderholm B, Martens J, Middleton L, Murray M, Kelly C, Nilsson C, Nowaczyk M, Peeters S, Peric A, Porter P, Schröder C, Rubio IT, Ruddy KJ, van Asperen C, Van Den Weyngaert D, van Deurzen C, van Leeuwen-Stok E, Vermeij J, Winer E, Giordano SH, Cardoso F, Bartlett JMS. Bayani J, et al. NPJ Breast Cancer. 2021 Jul 26;7(1):98. doi: 10.1038/s41523-021-00301-0. NPJ Breast Cancer. 2021. PMID: 34312396 Free PMC article.
Authors' reply.
Spears M, Cunningham CA, Taylor KJ, Mallon EA, Thomas JS, Kerr GR, Jack WJ, Kunkler IH, Cameron DA, Chetty U, Bartlett JM. Spears M, et al. Among authors: cunningham ca. J Pathol. 2013 Feb;229(3):e2-3. doi: 10.1002/path.4144. J Pathol. 2013. PMID: 23152120 No abstract available.
Assistive AI in Lung Cancer Screening: A Retrospective Multinational Study in the United States and Japan.
Kiraly AP, Cunningham CA, Najafi R, Nabulsi Z, Yang J, Lau C, Ledsam JR, Ye W, Ardila D, McKinney SM, Pilgrim R, Liu Y, Saito H, Shimamura Y, Etemadi M, Melnick D, Jansen S, Corrado GS, Peng L, Tse D, Shetty S, Prabhakara S, Naidich DP, Beladia N, Eswaran K. Kiraly AP, et al. Among authors: cunningham ca. Radiol Artif Intell. 2024 Mar 13:e230079. doi: 10.1148/ryai.230079. Online ahead of print. Radiol Artif Intell. 2024. PMID: 38477661
28-Year-Old Woman With Refractory Hypoxemia.
Cunningham CA, Rappaport DE. Cunningham CA, et al. Mayo Clin Proc. 2023 Dec;98(12):1863-1868. doi: 10.1016/j.mayocp.2023.04.020. Mayo Clin Proc. 2023. PMID: 38044001 No abstract available.
85 results